INCR
InterCure Ltd.NASDAQHealthcare$0.76-1.73%ClosedMarket Cap: $41.6M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.31
P/S
0.69
EV/EBITDA
-7.94
DCF Value
$-29.71
FCF Yield
6.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
21.7%
Operating Margin
-17.8%
Net Margin
-19.5%
ROE
-8.7%
ROA
-4.8%
ROIC
-4.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $65.0M | $-852.0K | $-0.02 |
| Q1 2025 | $65.0M | $-852.0K | $-0.02 |
| Q4 2024 | $56.6M | $-34.6M | $-0.79 |
| FY 2024 | $238.8M | $-67.8M | $-1.42 |
Trading Activity
Insider Trades
View AllGaenzle Christopher Lofficer: CAO, GC & Sec
SellTue Sep 19
Gaenzle Christopher Lofficer: CAO, GC & Sec
SellTue Sep 19
Rush Gregory Sofficer: Chief Financial Officer
SellTue Sep 19
Rush Gregory Sofficer: Chief Financial Officer
SellTue Sep 05
Rush Gregory Sofficer: Chief Financial Officer
SellTue Sep 05
Company Info
Sector
Healthcare
Industry
—
Country
IL
Exchange
NASDAQ
Beta
0.33
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.